Technology News and Research

RSS

Acquired resistance to cancer therapies: an interview with Dr Rajendra Kumari, Chief Scientific Officer at PRECOS

Cancer can be treated by a number of different ways depending on the location, grade and stage of tumour. A patient's age, medical history and lifestyle will also be taken into consideration and a combination of treatments will also be adopted to provide maximum effect.

14 Nov 2013

Nutranomics to distribute Nutriband transdermal delivery system in North America

Nutranomics, Inc. is pleased to announce that the Company has acquired the exclusive North American sales and distribution rights to the Nutriband delivery system, an innovative and commercialized health supplement transdermal patch system currently available in Europe.

14 Nov 2013

New research devises effective way to evaluate severity of pulmonary hypertension

An aim to improve the outlook for people suffering from pulmonary hypertension is the focus of research at Griffith University.

14 Nov 2013

Johns Hopkins students take the top honor for developing PrestoPatch system

A Johns Hopkins undergraduate biomedical engineering student team that devised a two-part system to improve the way life-saving shocks are delivered to hearts earned first-prize in the undergraduate division of a national Collegiate Inventors Competition. In the graduate-level competition, Isaac Kinde, a Johns Hopkins medical student, received third-place honors for developing a test to detect ovarian and endometrial cancers as part of a team at the Johns Hopkins Kimmel Cancer Center.

14 Nov 2013

Hand-held nanotech breathalyzer helps monitor blood glucose in diabetics

A novel hand-held, noninvasive monitoring device that uses multilayer nanotechnology to detect acetone has been shown to correlate with blood-glucose levels in the breath of diabetics. This research is being presented at the 2013 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in San Antonio, Nov. 10-14.

14 Nov 2013

Skeletal problems now added to list of diabetes complications

The list of complications from type 2 diabetes is long: vascular and heart disease, eye problems, nerve damage, kidney disease, hearing problems and Alzheimer's disease. Physicians have long thought of osteoporosis as another outcome. Based on a Mayo Clinic study published in the Journal of Bone and Mineral Research, that's confirmed: You can definitely add skeletal problems to that list.

14 Nov 2013

Polymer for mending broken bones holds hope for delivering chemotherapy drugs to the brain

A polymer originally designed to help mend broken bones could be successful in delivering chemotherapy drugs directly to the brains of patients suffering from brain tumours, researchers at The University of Nottingham have discovered.

14 Nov 2013

High-power blue laser gadgets can cause serious eye damage

A type of high-power blue laser toy readily available over the Internet and increasingly popular among male teens and young adults can cause serious, sometimes irreversible, eye damage, according to a report by investigators from Saudi Arabia’s King Khaled Eye Specialist Hospital and Johns Hopkins Medicine.

14 Nov 2013

The LGL Group third quarter 2013 total revenues decrease 16.5%

The LGL Group, Inc., announced results for the three and nine months ended September 30, 2013.

14 Nov 2013

Novel study explores effects of meditation on the heart and vascular system

Demystifying meditation with science, researchers at the Scripps Translational Science Institute have teamed with The Chopra Foundation and The Chopra Center for Wellbeing in a novel study of the ancient practice that uses wireless health sensors to collect physiological data from meditators.

14 Nov 2013

TAU researchers join top scientists in Switzerland to kick off neuroscience project

Between October 6 and 11, 2013, Tel Aviv University researchers participated in the kickoff in Switzerland of the Human Brain Project, a decade-long global initiative to leverage human intelligence and computing power to better understand the human brain.

14 Nov 2013

OvaScience reports net loss of $6.9 million in Q3 2013

OvaScienceSM, a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, today reported financial results for the quarter ended September 30, 2013, as well as recent highlights.

14 Nov 2013

DATATRAK International reports 21% increase in third quarter 2013 revenue

DATATRAK International, Inc., the leader in developing cloud-based, unified eClinical technologies and delivering related services for the clinical trials industry, today announced its operating results for the third quarter of 2013.

13 Nov 2013

SCHOTT announces the rebranding of its glass syringes

...

13 Nov 2013

Stem cells from Wolfram syndrome patients used to elucidate beta-cell failure pathway in diabetes

Scientists from the New York Stem Cell Foundation Research Institute and Columbia University Medical Center have used stem cells created from the skin of patients with a rare form of diabetes—Wolfram syndrome—to elucidate an important biochemical pathway for beta-cell failure in diabetes. The findings by Linshan Shang and colleagues were published today in Diabetes.

13 Nov 2013

Neovasc's Tiara transcatheter mitral valve replacement technology gets US patent

Neovasc Inc. today announced that the first patent covering the company's innovative Tiara transcatheter mitral valve replacement technology has been issued by the US Patent and Trademark Office.

13 Nov 2013

First Edition: November 13, 2013

Today's headlines include not-so-positive predictions about whether healthcare.gov will be fully functional by the end of November.

13 Nov 2013

AMP 2013: EKF Molecular Diagnostics to launch four new PointMan DNA enrichment kits

EKF Diagnostics, the global diagnostics business, announces that EKF Molecular Diagnostics will launch four new PointMan DNA enrichment kits.

From EKF Diagnostics 13 Nov 2013

immatics, Roche enter into cancer vaccine and immunotherapy deal

immatics biotechnologies GmbH and Roche today announced a strategic research and development collaboration covering multiple cancer vaccines and immunotherapeutics.

13 Nov 2013

Viewpoints: Health law foes wage battle to keep young adults from coverage; Sen. Rubio: Website's snags could open the door to con artists

This is the strangest P.R. campaign yet against the Affordable Care Act. Generation Opportunity, the Koch-funded group behind the Creepy Uncle Sam ads, is throwing tailgate parties to "educate" young people about the exchanges. Read: To convince young people to forgo health insurance.

13 Nov 2013

Technology News and Research

Acquired resistance to cancer therapies: an interview with Dr Rajendra Kumari, Chief Scientific Officer at PRECOS

Nutranomics to distribute Nutriband transdermal delivery system in North America

New research devises effective way to evaluate severity of pulmonary hypertension

Johns Hopkins students take the top honor for developing PrestoPatch system

Hand-held nanotech breathalyzer helps monitor blood glucose in diabetics

Skeletal problems now added to list of diabetes complications

Polymer for mending broken bones holds hope for delivering chemotherapy drugs to the brain

High-power blue laser gadgets can cause serious eye damage

The LGL Group third quarter 2013 total revenues decrease 16.5%

Novel study explores effects of meditation on the heart and vascular system

TAU researchers join top scientists in Switzerland to kick off neuroscience project

OvaScience reports net loss of $6.9 million in Q3 2013

DATATRAK International reports 21% increase in third quarter 2013 revenue

SCHOTT announces the rebranding of its glass syringes

Stem cells from Wolfram syndrome patients used to elucidate beta-cell failure pathway in diabetes

Neovasc's Tiara transcatheter mitral valve replacement technology gets US patent

First Edition: November 13, 2013

AMP 2013: EKF Molecular Diagnostics to launch four new PointMan DNA enrichment kits

immatics, Roche enter into cancer vaccine and immunotherapy deal

Viewpoints: Health law foes wage battle to keep young adults from coverage; Sen. Rubio: Website's snags could open the door to con artists

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News